Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performance and Effectiveness

Stryker logo

Stryker

Status

Invitation-only

Conditions

Craniofacial Injuries
Craniofacial Abnormalities
Cranioplasty

Treatments

Device: Stryker's PEEK Customized Implant

Study type

Observational

Funder types

Industry

Identifiers

NCT05362370
CMF_2021_01

Details and patient eligibility

About

The purpose of this study is to confirm the safety, performance and effectiveness of Stryker's PEEK Customized Implants when used for the augmentation and/or restoration of bony and/or soft tissue deformities in the cranial and craniofacial skeleton. The study is designed as a prospective, multi-center trial with a long-term follow-up (24 months) of study participants.

Full description

Stryker's PEEK Customized Implants are patient-specific implants based on CT-data of the individual patient and input of the surgeon. The implants are fabricated from Polyetheretherketone (PEEK) and intended to be used to fill bony voids in the cranial and craniofacial region (e.g. cranium, orbital rim, zygoma, and adjacent bone). This observational post-market clinical follow-up (PMCF) is designed to confirm the safety, performance and clinical benefit of Stryker's PEEK Customized Implants for the augmentation and/or restoration of bony and/or soft tissue deformities in the cranial and craniofacial skeleton (orbital rim, zygoma, and adjacent bone); including but not limited to, the correction and prevention of persistent temporal hollowing (PTH). Infection of implants is one of the common risks associated with this type of surgery. This PMCF study will investigate infection rate as the primary safety endpoint. These data will be collected in a real world setting, where all treatment is per routine clinical practice. The study is designed as a prospective, multi-center trial at participating institutions in the United States and in Europe. Up to 110 study participants will be enrolled in this PMCF. Stryker's PEEK Customized Implants are intended to stay implanted permanently. Therefore, study participants will be followed for 24 months after implantation of the devices to allow evaluation of long-term safety and performance of the products.

Enrollment

110 estimated patients

Sex

All

Ages

42+ months old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Subject is eligible for a PEEK customized implant as per routine clinical practice.
  • Subject is 12 years of age or older (Europe only).
  • Subject is 3.5 years of age or older (USA only).
  • Adult subjects able to give consent.
  • Subjects under the age of 18 will have a legal representative or parents (France - both parents must sign) to provide informed consent.
  • Subjects who are unable to give consent themselves but have a legally authorized representative that may consent on their behalf.

Exclusion Criteria

  • Subject has an active systemic or local infection.
  • Subject has known allergy to plastic or polymers and/or known sensitivity to foreign bodies.
  • Comprised bone due to poor blood supply, disease, infection or prior implantation, which would not allow adequate support or fixation of the implant.
  • Mental or neuromuscular disorder which could create an unacceptable risk of implant instability or implant fixation failure, or complications in postoperative care.
  • Knowingly pregnant or nursing women.
  • Concomitant participation in other clinical trials related to cranioplasty.
  • Subject who has an expected survival rate of less than 2 years, in the opinion of the investigator who takes consent.

Trial design

110 participants in 1 patient group

Cohort 1
Description:
Participants will receive a Stryker PEEK Customized Implant
Treatment:
Device: Stryker's PEEK Customized Implant

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems